First Light Asset Management »

Peregrine Pharmaceuticals shares owned by First Light Asset Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $32M 2.8M 11.38

More positions owned by First Light Asset Management

Paragon 28 Common Stocks (FNA)
Centessa Pharmaceuticals Common Stocks (CNTA)
Axogen Common Stocks (AXGN)
Atricure Common Stocks (ATRC)
Twist Bioscience Corporation Common Stocks (TWST)
Vera Therapeutics Common Stocks (VERA)
Neogenomics Common Stocks (NEO)
Xenon Pharmaceuticals Common Stocks (XENE)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Irhythm Technologies Common Stocks (IRTC)
Health Catalyst Common Stocks (HCAT)
Performant Healthcare Common Stocks
Insmed Common Stocks (INSM)
Mimedx Group Common Stocks (MDXG)
Ultragenyx Pharmaceutical Common Stocks (RARE)

View all positions for First Light Asset Management

Top funds holding Peregrine Pharmaceuticals

BlackRock
AltraVue Capital
Vanguard Group
Glazer Capital
Punch & Associates Investment Management
State Street Corporation
Fil
Royal Bank of Canada
Goldman Sachs Group
Alpine Associates Management
Highland Capital Management Fund Advisors
Water Island Capital
CNH Partners
Hsbc Holdings
Geode Capital Management

View all funds holding Peregrine Pharmaceuticals